0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sevoflurane Anesthesia Drugs Market Research Report 2026
Published Date: 2026-04-29
|
Report Code: QYRE-Auto-6C18209
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sevoflurane Anesthesia Drugs Market Research Report 2024
BUY CHAPTERS

Global Sevoflurane Anesthesia Drugs Market Research Report 2026

Code: QYRE-Auto-6C18209
Report
2026-04-29
Pages:117
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Sevoflurane Anesthesia Drugs Market Size

The global Sevoflurane Anesthesia Drugs market was valued at US$ 1309 million in 2025 and is anticipated to reach US$ 1736 million by 2032, at a CAGR of 4.2% from 2026 to 2032.

Sevoflurane Anesthesia Drugs Market

Sevoflurane Anesthesia Drugs Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Sevoflurane Anesthesia Drugs competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Sevoflurane is a volatile anesthetic commonly used for induction and maintenance of general anesthesia during surgical procedures. It is favored for its rapid onset and offset of action, making it ideal for both adults and pediatric patients. Sevoflurane is typically inhaled and works by depressing the central nervous system, leading to a reversible loss of consciousness and sensation. Its minimal airway irritation and low blood solubility contribute to smoother anesthesia induction and quicker recovery times compared to other anesthetics. Sevoflurane is widely used due to its safety profile and ease of administration.
The key driver for the Sevoflurane market is the increasing number of surgeries worldwide, driven by the aging population and the rising prevalence of chronic conditions requiring surgical intervention. Sevoflurane is highly preferred due to its rapid onset and recovery, making it ideal for both pediatric and adult patients, particularly in outpatient surgeries. Technological advancements in anesthesia delivery systems and the growing demand for minimally invasive procedures have also contributed to the rising adoption of Sevoflurane in clinical settings. Furthermore, the safety and effectiveness of Sevoflurane in maintaining stable cardiovascular function during anesthesia have enhanced its demand.
One of the main challenges in the Sevoflurane market is its high cost compared to other anesthetic agents, which can limit its accessibility in low- and middle-income regions. Additionally, environmental concerns regarding the use of volatile anesthetics like Sevoflurane, which contribute to greenhouse gas emissions, have led to increased scrutiny and calls for more sustainable alternatives. Regulatory restrictions and the availability of generic alternatives may further impact the market growth, as healthcare providers seek more cost-effective or environmentally friendly options.
China is the largest consumption place, with a revenue market share nearly 40.71% in 2023. Following China, North Americas is the second largest consumption place with the revenue market share of 25.08%.
The global key manufacturers of Sevoflurane Anesthesia Drugs include Hengrui, Baxter, Maruishi, AbbVie, Piramal, PT Novell Pharmaceutical, Lunan Pharma, Hana Pharm, Hebei Yipin Pharmaceutical, etc. In 2023, the global top five players had a share approximately 91.92% in terms of revenue.
This report delivers a comprehensive overview of the global Sevoflurane Anesthesia Drugs market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Sevoflurane Anesthesia Drugs. The Sevoflurane Anesthesia Drugs market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Sevoflurane Anesthesia Drugs market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Sevoflurane Anesthesia Drugs manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Sevoflurane Anesthesia Drugs Market Report

Report Metric Details
Report Name Sevoflurane Anesthesia Drugs Market
Accounted market size in 2025 US$ 1309 million
Forecasted market size in 2032 US$ 1736 million
CAGR 4.2%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • 250ml/Bottle
  • 120ml/Bottle
  • Other
by Application
  • Hospital
  • Clinic
  • Other
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Hengrui, Baxter, Maruishi, AbbVie, Piramal, Hebei Yipin Pharmaceutical, PT Novell Pharmaceutical, Lunan Pharma, Hana Pharm
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Sevoflurane Anesthesia Drugs manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Sevoflurane Anesthesia Drugs sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Sevoflurane Anesthesia Drugs Market growing?

Ans: The Sevoflurane Anesthesia Drugs Market witnessing a CAGR of 4.2% during the forecast period 2026-2032.

What is the Sevoflurane Anesthesia Drugs Market size in 2032?

Ans: The Sevoflurane Anesthesia Drugs Market size in 2032 will be US$ 1736 million.

What is the Sevoflurane Anesthesia Drugs Market share by region?

Ans: China is the largest consumption place, with a revenue market share nearly 40.71% in 2023.

What is the market share of major companies in Sevoflurane Anesthesia Drugs Market?

Ans: In 2023, the global top five players had a share approximately 91.92% in terms of revenue.

Who are the main players in the Sevoflurane Anesthesia Drugs Market report?

Ans: The main players in the Sevoflurane Anesthesia Drugs Market are Hengrui, Baxter, Maruishi, AbbVie, Piramal, Hebei Yipin Pharmaceutical, PT Novell Pharmaceutical, Lunan Pharma, Hana Pharm

What are the Application segmentation covered in the Sevoflurane Anesthesia Drugs Market report?

Ans: The Applications covered in the Sevoflurane Anesthesia Drugs Market report are Hospital, Clinic, Other

What are the Type segmentation covered in the Sevoflurane Anesthesia Drugs Market report?

Ans: The Types covered in the Sevoflurane Anesthesia Drugs Market report are 250ml/Bottle, 120ml/Bottle, Other

1 Sevoflurane Anesthesia Drugs Market Overview
1.1 Product Definition
1.2 Sevoflurane Anesthesia Drugs by Type
1.2.1 Global Sevoflurane Anesthesia Drugs Market Value by Type: 2025 vs 2032
1.2.2 250ml/Bottle
1.2.3 120ml/Bottle
1.2.4 Other
1.3 Sevoflurane Anesthesia Drugs by Application
1.3.1 Global Sevoflurane Anesthesia Drugs Market Value by Application: 2025 vs 2032
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Global Sevoflurane Anesthesia Drugs Market Size Estimates and Forecasts
1.4.1 Global Sevoflurane Anesthesia Drugs Revenue 2021–2032
1.4.2 Global Sevoflurane Anesthesia Drugs Sales 2021–2032
1.4.3 Global Sevoflurane Anesthesia Drugs Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Sevoflurane Anesthesia Drugs Market Competition by Manufacturers
2.1 Global Sevoflurane Anesthesia Drugs Sales Market Share by Manufacturers (2021–2026)
2.2 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Sevoflurane Anesthesia Drugs Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Sevoflurane Anesthesia Drugs, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Product Types and Applications
2.7 Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Date of Entry into the Industry
2.8 Global Sevoflurane Anesthesia Drugs Market Competitive Situation and Trends
2.8.1 Global Sevoflurane Anesthesia Drugs Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Sevoflurane Anesthesia Drugs Players Market Share by Revenue
2.8.3 Global Sevoflurane Anesthesia Drugs Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Sevoflurane Anesthesia Drugs Market Scenario by Region
3.1 Global Sevoflurane Anesthesia Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Sevoflurane Anesthesia Drugs Sales by Region: 2021–2032
3.2.1 Global Sevoflurane Anesthesia Drugs Sales by Region: 2021–2026
3.2.2 Global Sevoflurane Anesthesia Drugs Sales by Region: 2027–2032
3.3 Global Sevoflurane Anesthesia Drugs Revenue by Region: 2021–2032
3.3.1 Global Sevoflurane Anesthesia Drugs Revenue by Region: 2021–2026
3.3.2 Global Sevoflurane Anesthesia Drugs Revenue by Region: 2027–2032
3.4 North America Sevoflurane Anesthesia Drugs Market Facts & Figures by Country
3.4.1 North America Sevoflurane Anesthesia Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Sevoflurane Anesthesia Drugs Sales by Country (2021–2032)
3.4.3 North America Sevoflurane Anesthesia Drugs Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Sevoflurane Anesthesia Drugs Market Facts & Figures by Country
3.5.1 Europe Sevoflurane Anesthesia Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Sevoflurane Anesthesia Drugs Sales by Country (2021–2032)
3.5.3 Europe Sevoflurane Anesthesia Drugs Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Sevoflurane Anesthesia Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Sevoflurane Anesthesia Drugs Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Sevoflurane Anesthesia Drugs Sales by Region (2021–2032)
3.6.3 Asia Pacific Sevoflurane Anesthesia Drugs Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Sevoflurane Anesthesia Drugs Market Facts & Figures by Country
3.7.1 Latin America Sevoflurane Anesthesia Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Sevoflurane Anesthesia Drugs Sales by Country (2021–2032)
3.7.3 Latin America Sevoflurane Anesthesia Drugs Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Sevoflurane Anesthesia Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Sevoflurane Anesthesia Drugs Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Sevoflurane Anesthesia Drugs Sales by Country (2021–2032)
3.8.3 Middle East and Africa Sevoflurane Anesthesia Drugs Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Sevoflurane Anesthesia Drugs Sales by Type (2021–2032)
4.1.1 Global Sevoflurane Anesthesia Drugs Sales by Type (2021–2026)
4.1.2 Global Sevoflurane Anesthesia Drugs Sales by Type (2027–2032)
4.1.3 Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2021–2032)
4.2 Global Sevoflurane Anesthesia Drugs Revenue by Type (2021–2032)
4.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Type (2021–2026)
4.2.2 Global Sevoflurane Anesthesia Drugs Revenue by Type (2027–2032)
4.2.3 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2021–2032)
4.3 Global Sevoflurane Anesthesia Drugs Price by Type (2021–2032)
5 Segment by Application
5.1 Global Sevoflurane Anesthesia Drugs Sales by Application (2021–2032)
5.1.1 Global Sevoflurane Anesthesia Drugs Sales by Application (2021–2026)
5.1.2 Global Sevoflurane Anesthesia Drugs Sales by Application (2027–2032)
5.1.3 Global Sevoflurane Anesthesia Drugs Sales Market Share by Application (2021–2032)
5.2 Global Sevoflurane Anesthesia Drugs Revenue by Application (2021–2032)
5.2.1 Global Sevoflurane Anesthesia Drugs Revenue by Application (2021–2026)
5.2.2 Global Sevoflurane Anesthesia Drugs Revenue by Application (2027–2032)
5.2.3 Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2021–2032)
5.3 Global Sevoflurane Anesthesia Drugs Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Hengrui
6.1.1 Hengrui Company Information
6.1.2 Hengrui Description and Business Overview
6.1.3 Hengrui Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Hengrui Sevoflurane Anesthesia Drugs Product Portfolio
6.1.5 Hengrui Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Company Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 Baxter Sevoflurane Anesthesia Drugs Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 Maruishi
6.3.1 Maruishi Company Information
6.3.2 Maruishi Description and Business Overview
6.3.3 Maruishi Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Maruishi Sevoflurane Anesthesia Drugs Product Portfolio
6.3.5 Maruishi Recent Developments/Updates
6.4 AbbVie
6.4.1 AbbVie Company Information
6.4.2 AbbVie Description and Business Overview
6.4.3 AbbVie Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 AbbVie Sevoflurane Anesthesia Drugs Product Portfolio
6.4.5 AbbVie Recent Developments/Updates
6.5 Piramal
6.5.1 Piramal Company Information
6.5.2 Piramal Description and Business Overview
6.5.3 Piramal Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Piramal Sevoflurane Anesthesia Drugs Product Portfolio
6.5.5 Piramal Recent Developments/Updates
6.6 Hebei Yipin Pharmaceutical
6.6.1 Hebei Yipin Pharmaceutical Company Information
6.6.2 Hebei Yipin Pharmaceutical Description and Business Overview
6.6.3 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Product Portfolio
6.6.5 Hebei Yipin Pharmaceutical Recent Developments/Updates
6.7 PT Novell Pharmaceutical
6.7.1 PT Novell Pharmaceutical Company Information
6.7.2 PT Novell Pharmaceutical Description and Business Overview
6.7.3 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product Portfolio
6.7.5 PT Novell Pharmaceutical Recent Developments/Updates
6.8 Lunan Pharma
6.8.1 Lunan Pharma Company Information
6.8.2 Lunan Pharma Description and Business Overview
6.8.3 Lunan Pharma Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Lunan Pharma Sevoflurane Anesthesia Drugs Product Portfolio
6.8.5 Lunan Pharma Recent Developments/Updates
6.9 Hana Pharm
6.9.1 Hana Pharm Company Information
6.9.2 Hana Pharm Description and Business Overview
6.9.3 Hana Pharm Sevoflurane Anesthesia Drugs Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Hana Pharm Sevoflurane Anesthesia Drugs Product Portfolio
6.9.5 Hana Pharm Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Sevoflurane Anesthesia Drugs Industry Chain Analysis
7.2 Sevoflurane Anesthesia Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Sevoflurane Anesthesia Drugs Production Mode & Process Analysis
7.4 Sevoflurane Anesthesia Drugs Sales and Marketing
7.4.1 Sevoflurane Anesthesia Drugs Sales Channels
7.4.2 Sevoflurane Anesthesia Drugs Distributors
7.5 Sevoflurane Anesthesia Drugs Customer Analysis
8 Sevoflurane Anesthesia Drugs Market Dynamics
8.1 Sevoflurane Anesthesia Drugs Industry Trends
8.2 Sevoflurane Anesthesia Drugs Market Drivers
8.3 Sevoflurane Anesthesia Drugs Market Challenges
8.4 Sevoflurane Anesthesia Drugs Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Sevoflurane Anesthesia Drugs Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Sevoflurane Anesthesia Drugs Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Sevoflurane Anesthesia Drugs Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Sevoflurane Anesthesia Drugs Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Sevoflurane Anesthesia Drugs Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Sevoflurane Anesthesia Drugs Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Sevoflurane Anesthesia Drugs Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Sevoflurane Anesthesia Drugs Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Sevoflurane Anesthesia Drugs, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Product Types and Applications
 Table 12. Global Key Manufacturers of Sevoflurane Anesthesia Drugs, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Sevoflurane Anesthesia Drugs Companies by Tier (Tier 1, Tier 2, Tier 3), based on Sevoflurane Anesthesia Drugs Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Sevoflurane Anesthesia Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Sevoflurane Anesthesia Drugs Sales by Region (K Units), 2021–2026
 Table 18. Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2021–2026)
 Table 19. Global Sevoflurane Anesthesia Drugs Sales by Region (K Units), 2027–2032
 Table 20. Global Sevoflurane Anesthesia Drugs Sales Market Share by Region (2027–2032)
 Table 21. Global Sevoflurane Anesthesia Drugs Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2021–2026)
 Table 23. Global Sevoflurane Anesthesia Drugs Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2027–2032)
 Table 25. North America Sevoflurane Anesthesia Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2021–2026
 Table 27. North America Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2027–2032
 Table 28. North America Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Sevoflurane Anesthesia Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2021–2026
 Table 32. Europe Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2027–2032
 Table 33. Europe Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Sevoflurane Anesthesia Drugs Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Sevoflurane Anesthesia Drugs Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Sevoflurane Anesthesia Drugs Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Sevoflurane Anesthesia Drugs Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Sevoflurane Anesthesia Drugs Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Sevoflurane Anesthesia Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2021–2026
 Table 42. Latin America Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2027–2032
 Table 43. Latin America Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Sevoflurane Anesthesia Drugs Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Sevoflurane Anesthesia Drugs Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Sevoflurane Anesthesia Drugs Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Sevoflurane Anesthesia Drugs Sales (K Units) by Type (2021–2026)
 Table 51. Global Sevoflurane Anesthesia Drugs Sales (K Units) by Type (2027–2032)
 Table 52. Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2021–2026)
 Table 53. Global Sevoflurane Anesthesia Drugs Sales Market Share by Type (2027–2032)
 Table 54. Global Sevoflurane Anesthesia Drugs Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Sevoflurane Anesthesia Drugs Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2021–2026)
 Table 57. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Type (2027–2032)
 Table 58. Global Sevoflurane Anesthesia Drugs Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Sevoflurane Anesthesia Drugs Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Sevoflurane Anesthesia Drugs Sales (K Units) by Application (2021–2026)
 Table 61. Global Sevoflurane Anesthesia Drugs Sales (K Units) by Application (2027–2032)
 Table 62. Global Sevoflurane Anesthesia Drugs Sales Market Share by Application (2021–2026)
 Table 63. Global Sevoflurane Anesthesia Drugs Sales Market Share by Application (2027–2032)
 Table 64. Global Sevoflurane Anesthesia Drugs Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Sevoflurane Anesthesia Drugs Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2021–2026)
 Table 67. Global Sevoflurane Anesthesia Drugs Revenue Market Share by Application (2027–2032)
 Table 68. Global Sevoflurane Anesthesia Drugs Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Sevoflurane Anesthesia Drugs Price (US$/Unit) by Application (2027–2032)
 Table 70. Hengrui Company Information
 Table 71. Hengrui Description and Business Overview
 Table 72. Hengrui Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Hengrui Sevoflurane Anesthesia Drugs Product
 Table 74. Hengrui Recent Developments/Updates
 Table 75. Baxter Company Information
 Table 76. Baxter Description and Business Overview
 Table 77. Baxter Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. Baxter Sevoflurane Anesthesia Drugs Product
 Table 79. Baxter Recent Developments/Updates
 Table 80. Maruishi Company Information
 Table 81. Maruishi Description and Business Overview
 Table 82. Maruishi Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Maruishi Sevoflurane Anesthesia Drugs Product
 Table 84. Maruishi Recent Developments/Updates
 Table 85. AbbVie Company Information
 Table 86. AbbVie Description and Business Overview
 Table 87. AbbVie Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. AbbVie Sevoflurane Anesthesia Drugs Product
 Table 89. AbbVie Recent Developments/Updates
 Table 90. Piramal Company Information
 Table 91. Piramal Description and Business Overview
 Table 92. Piramal Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Piramal Sevoflurane Anesthesia Drugs Product
 Table 94. Piramal Recent Developments/Updates
 Table 95. Hebei Yipin Pharmaceutical Company Information
 Table 96. Hebei Yipin Pharmaceutical Description and Business Overview
 Table 97. Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. Hebei Yipin Pharmaceutical Sevoflurane Anesthesia Drugs Product
 Table 99. Hebei Yipin Pharmaceutical Recent Developments/Updates
 Table 100. PT Novell Pharmaceutical Company Information
 Table 101. PT Novell Pharmaceutical Description and Business Overview
 Table 102. PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. PT Novell Pharmaceutical Sevoflurane Anesthesia Drugs Product
 Table 104. PT Novell Pharmaceutical Recent Developments/Updates
 Table 105. Lunan Pharma Company Information
 Table 106. Lunan Pharma Description and Business Overview
 Table 107. Lunan Pharma Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Lunan Pharma Sevoflurane Anesthesia Drugs Product
 Table 109. Lunan Pharma Recent Developments/Updates
 Table 110. Hana Pharm Company Information
 Table 111. Hana Pharm Description and Business Overview
 Table 112. Hana Pharm Sevoflurane Anesthesia Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Hana Pharm Sevoflurane Anesthesia Drugs Product
 Table 114. Hana Pharm Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Sevoflurane Anesthesia Drugs Distributors List
 Table 118. Sevoflurane Anesthesia Drugs Customers List
 Table 119. Sevoflurane Anesthesia Drugs Market Trends
 Table 120. Sevoflurane Anesthesia Drugs Market Drivers
 Table 121. Sevoflurane Anesthesia Drugs Market Challenges
 Table 122. Sevoflurane Anesthesia Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Sevoflurane Anesthesia Drugs
 Figure 2. Global Sevoflurane Anesthesia Drugs Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Sevoflurane Anesthesia Drugs Market Share by Type: 2025 & 2032
 Figure 4. 250ml/Bottle Product Picture
 Figure 5. 120ml/Bottle Product Picture
 Figure 6. Other Product Picture
 Figure 7. Global Sevoflurane Anesthesia Drugs Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Sevoflurane Anesthesia Drugs Market Share by Application: 2025 & 2032
 Figure 9. Hospital
 Figure 10. Clinic
 Figure 11. Other
 Figure 12. Global Sevoflurane Anesthesia Drugs Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Sevoflurane Anesthesia Drugs Market Size (US$ Million), 2021–2032
 Figure 14. Global Sevoflurane Anesthesia Drugs Sales (K Units), 2021–2032
 Figure 15. Global Sevoflurane Anesthesia Drugs Average Price (US$/Unit), 2021–2032
 Figure 16. Sevoflurane Anesthesia Drugs Report Years Considered
 Figure 17. Sevoflurane Anesthesia Drugs Sales Share by Manufacturers in 2025
 Figure 18. Global Sevoflurane Anesthesia Drugs Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Sevoflurane Anesthesia Drugs Players: Market Share by Revenue in Sevoflurane Anesthesia Drugs in 2025
 Figure 20. Sevoflurane Anesthesia Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Sevoflurane Anesthesia Drugs Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Sevoflurane Anesthesia Drugs Sales Market Share by Country (2021–2032)
 Figure 23. North America Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2021–2032)
 Figure 24. United States Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Sevoflurane Anesthesia Drugs Sales Market Share by Country (2021–2032)
 Figure 27. Europe Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Sevoflurane Anesthesia Drugs Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Sevoflurane Anesthesia Drugs Revenue Market Share by Region (2021–2032)
 Figure 35. China Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Sevoflurane Anesthesia Drugs Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Sevoflurane Anesthesia Drugs Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Sevoflurane Anesthesia Drugs Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Sevoflurane Anesthesia Drugs Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Sevoflurane Anesthesia Drugs by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Sevoflurane Anesthesia Drugs by Type (2021–2032)
 Figure 55. Global Sevoflurane Anesthesia Drugs Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Sevoflurane Anesthesia Drugs by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Sevoflurane Anesthesia Drugs by Application (2021–2032)
 Figure 58. Global Sevoflurane Anesthesia Drugs Price (US$/Unit) by Application (2021–2032)
 Figure 59. Sevoflurane Anesthesia Drugs Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Bioinformatics Barcelona